We are live on ! Find out more
WA

Wilshire Advisors Portfolio holdings

AUM $9.96M
1-Year Est. Return 76.57%
This Fund
S&P 500
This Quarter Est. Return
-0.66%
1 Year Est. Return
+76.57%
3 Year Est. Return
+100.3%
5 Year Est. Return
+82.67%
10 Year Est. Return
+137%
AUM
$106M
AUM Growth
-$1.11M
Cap. Flow
+$138K
Cap. Flow %
0.13%
Top 10 Hldgs %
72.85%
Holding
26
New
1
Increased
11
Reduced
11
Closed
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGTC
26
DELISTED
Applied Genetic Technologies Corporation
AGTC
$42K 0.04%
+11,378
New +$52.6K

Similar funds

Wilshire Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Wilshire Advisors held 26 positions worth $106M, down 1% from $107M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Trading was light in Q2 2018: portfolio turnover was 3.8%. Wilshire Advisors opened 1 new position and made no exits, leaving the 26-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 0.08% of assets, down from 0.1% a quarter earlier, followed by Healthcare.

  • Wilshire Advisors's largest Q2 2018 buy was Applied Genetic Technologies Corporation: 11,378 shares worth $42K.
  • Wilshire Advisors added most to Vanguard S&P 500 ETF in Q2 2018, an estimated $1.22M increase.
  • Wilshire Advisors's biggest Q2 2018 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $1.28M.
  • Wilshire Advisors's ten largest holdings make up 73% of its $106M portfolio in Q2 2018.
  • Wilshire Advisors opened 1 new position and closed 0 in Q2 2018.
  • Wilshire Advisors's portfolio value fell 1% quarter-over-quarter to $106M.

Based on Wilshire Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.